Westbourne Investment Advisors Inc. Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Westbourne Investment Advisors Inc. lessened its position in shares of AbbVie Inc. (NYSE:ABBV – Get Rating) by 10.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,900 shares of the company’s stock after selling 935 shares during the period. Westbourne […]

Related Keywords

Westbourne ,Texas ,United States ,Jeffrey Ryan Stewart ,Azita Saleki Gerhardt ,Texas Capital Bank Wealth Management Services Inc ,Wells Fargo Company ,Everhart Financial Group Inc ,Citizens Financial Group Inc ,Securities Exchange Commission ,Barclays ,Abbvie Company Profile ,Westbourne Investment Advisors Inc ,Horizon Bancorp Inc ,Abbvie Inc ,Westbourne Investment Advisors ,Get Rating ,Investment Advisors ,Financial Group ,Financial Group Inc ,Capital Management ,Texas Capital Bank Wealth Management Services ,Capital Bank Wealth Management Services ,Ryan Stewart ,Vie Trading Down ,Visit Holdingschannel ,Abbvie Daily ,Abbvie ,Nyse Abbv ,Abbv ,Medical ,00287y10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,